《TAIPEI TIMES》 GBC seeks US authorization for

By Kao Shih-ching / Staff reporterGolden Biotechnology Corp （GBC, 國鼎） plans to apply for emergency use authorization in the US for its experimental COVID-19 drug after positive results in its phase 2 clinical trials, the company said.

Related Keywords

Taipei , T Ai Pei , Taiwan , Peru , Argentina , Liu Sheng Yung , Chen Yung Chi , Alan Tseng , Senhwa Biosciences Inc , Labcorp Drug Development , Taipei Exchange On , Taipei Exchange , Golden Biotechnology Corp , Taipei Times , Kao Shih Ching , Biotechnology Corp , Emerging Stock Board , 自由時報 , Iberty Times Net , Tn ,